Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin

This publication has 23 references indexed in Scilit:

• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
  Proceedings of the National Academy of Sciences, 1998
• Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesisin Vitro¹
  Endocrinology, 1998
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
  Nature, 1997
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells
  Journal of Biological Chemistry, 1997
• Regulation of Osteoclast Function
  Journal of Bone and Mineral Research, 1997
• Isolation of a Novel Cytokine from Human Fibroblasts That Specifically Inhibits Osteoclastogenesis
  Biochemical and Biophysical Research Communications, 1997
• Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
  Cell, 1997
• Modulation of osteoclast differentiation by local factors
  Bone, 1995
• The Bone Marrow-Derived Stromal Cell Lines MC3T3-G2/PA6 and ST2 Support Osteoclast-Like Cell Differentiation in Cocultures with Mouse Spleen Cells
  Endocrinology, 1989
• OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
  Endocrinology, 1988